Literature DB >> 6765535

Absorption kinetics of semisynthetic human insulin and biosynthetic (recombinant DNA) human insulin.

F W Kemmer, G Sonnenberg, H J Cüppers, M Berger.   

Abstract

Absorption kinetics of subcutaneously injected human insulin (recombinant DNA) and semisynthetic human regular insulin were investigated and compared to the respective porcine insulin preparations in normal volunteers. The absorption of all regular human insulin preparations tested was accelerated as compared to porcine insulins. The clinical relevance of these findings in regard to the treatment of diabetes mellitus appears to be doubtful. As for mixtures of porcine regular and intermediate-acting insulin preparations, the absorption of human regular insulin is not altered when mixed with intermediate-acting human insulin.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6765535     DOI: 10.2337/diacare.5.2.s23

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  8 in total

1.  Human insulin.

Authors:  J Pickup
Journal:  Br Med J (Clin Res Ed)       Date:  1986-01-18

2.  Human insulin.

Authors:  P Home
Journal:  Br Med J (Clin Res Ed)       Date:  1986-03-01

3.  Miscibility of semisynthetic human ultralente insulin with short-acting insulin in insulin-dependent diabetic patients.

Authors:  M Lunetta; M di Mauro; S Crimi; L Sudano; L Mughini
Journal:  Acta Diabetol Lat       Date:  1988 Jul-Sep

Review 4.  Human insulin: much ado about one amino acid?

Authors:  G E Sonnenberg; M Berger
Journal:  Diabetologia       Date:  1983-12       Impact factor: 10.122

Review 5.  Human insulin. A review of its biological activity, pharmacokinetics and therapeutic use.

Authors:  R N Brogden; R C Heel
Journal:  Drugs       Date:  1987-09       Impact factor: 9.546

6.  Kinetics of human and porcine insulins in normal and type I diabetic subjects.

Authors:  B Thorsteinsson; S Fugleberg; C Binder
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

7.  Circadian profiles of blood glucose and plasma free insulin during treatment with semisynthetic and biosynthetic human insulin, and comparison with conventional monocomponent preparations.

Authors:  M Castillo; A Nemery; E Verdin; P J Lefebvre; A S Luyckx
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

8.  The crystal structures of three non-pancreatic human insulins.

Authors:  S A Chawdhury; E J Dodson; G G Dodson; C D Reynolds; S P Tolley; T L Blundell; A Cleasby; J E Pitts; I J Tickle; S P Wood
Journal:  Diabetologia       Date:  1983-12       Impact factor: 10.122

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.